Antonio Monge
Impact in
- Toxicology top 0.1%
- Bioactive Compounds and Antitumor Agents
- Organic Chemistry top 0.5%
- Synthesis and Biological Evaluation
- Synthesis and biological activity
- Synthesis and Reactions of Organic Compounds
- Multicomponent Synthesis of Heterocycles
- Synthesis and Characterization of Heterocyclic Compounds
- Quinazolinone synthesis and applications
Papers in
- Toxicology 21
- Bioactive Compounds and Antitumor Agents 21
-
- Synthesis and Biological Evaluation 117
- Synthesis and Reactions of Organic Compounds 53
- Synthesis and biological activity 48
- Synthesis and Characterization of Heterocyclic Compounds 30
- Quinazolinone synthesis and applications 20
- Co-authors
- Ignacio AldanaSilvia Pérez‐SilanesBelén ZarranzAndrés JasoAdela López de CeráinMercedes GonzálezHugo CerecettoBeatriz Solano
In The Last Decade
Antonio Monge
190 papers receiving 4.7k citations
Peers
Comparison fields: 5 of 131
- Toxicology 618
- Organic Chemistry 3.6k
- Molecular Biology 1.1k
- Pharmacology 244
- Pharmaceutical Science 87
Countries citing papers authored by Antonio Monge
This map shows the geographic impact of Antonio Monge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Monge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Monge more than expected).
Fields of papers citing papers by Antonio Monge
This network shows the impact of papers produced by Antonio Monge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Monge. The network helps show where Antonio Monge may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Antonio Monge, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 14 | |
| 2 | 2017 | 32 | |
| 3 | 2017 | 23 | |
| 4 | Quinoxalinas como potenciales agentes Antimycobacterium tuberculosis: una revisión | 2013 | 2 |
| 5 | 2011 | 31 | |
| 6 | 2011 | 42 | |
| 7 | 2010 | 64 | |
| 8 | 2009 | 31 | |
| 9 | 2009 | 23 | |
| 10 | 2008 | 87 | |
| 11 | 2004 | 8 | |
| 12 | 2004 | 7 | |
| 13 | 2004 | 2 | |
| 14 | 2003 | 8 | |
| 15 | 2002 | 3 | |
| 16 | La Química Farmaceútica en el desarrollo de los pueblos, biodiversidad y productos naturales | 2001 | 0 |
| 17 | 2000 | 14 | |
| 18 | 1998 | 27 | |
| 19 | 1995 | 107 | |
| 20 | 1993 | 46 |
About Antonio Monge
Antonio Monge is a scholar working on Toxicology, Organic Chemistry, Cellular and Molecular Neuroscience, Pharmaceutical Science and Endocrine and Autonomic Systems, having authored 201 papers that have together received 4.8k indexed citations. Recurring topics across this work include Synthesis and Biological Evaluation (117 papers), Synthesis and Reactions of Organic Compounds (53 papers), Synthesis and biological activity (48 papers), Synthesis and Characterization of Heterocyclic Compounds (30 papers), Bioactive Compounds and Antitumor Agents (21 papers), Quinazolinone synthesis and applications (20 papers), Receptor Mechanisms and Signaling (14 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (14 papers). The work is most often cited by research in Toxicology (618 citations), Organic Chemistry (3.6k citations), Molecular Biology (1.1k citations), Pharmacology (244 citations) and Pharmaceutical Science (87 citations). Antonio Monge has collaborated with scholars based in Spain, Uruguay and Argentina. Frequent co-authors include Ignacio Aldana, Silvia Pérez‐Silanes, Belén Zarranz, Andrés Jaso, Adela López de Ceráin, Mercedes González, Hugo Cerecetto, Beatriz Solano, Juan Antonio Palop and Raquel Villar. Their work appears in journals such as Bioorganic & Medicinal Chemistry, European Journal of Medicinal Chemistry, Journal of Medicinal Chemistry, Molecules and Archiv der Pharmazie.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.